A Randomized, Double-blind, Placebo-controlled, Phase 3 Study of Apalutamide in Subjects with High-risk, Localized or Locally Advanced Prostate Cancer Who are Candidates for Radical Prostatectomy
Clinical Trial Grant
Administered By
Urology
Awarded By
Janssen Research & Development, LLC
Start Date
April 30, 2020
End Date
October 28, 2021
Administered By
Urology
Awarded By
Janssen Research & Development, LLC
Start Date
April 30, 2020
End Date
October 28, 2021